Financing, Equity Capital Markets

Inozyme Pharma, Inc.

07/23
|
$60.0 Million
Inozyme
Piper Sandler served as bookrunner for Inozyme Pharma, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$43.0 Million
CSC
CSC Leasing Company, Inc
Reopened Senior Unsecured Notes
Sole Placement Agent
$30.0 Million
milestone
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$75.0 Million
Velocity
Velocity Financial, Inc.
Senior Notes
Sole Placement Agent
$172.4 Million
Praxis
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
$150.0 Million
Catalyst
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$161.0 Million
Keros
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$410.0 Million
NB
The Needham Bank
Initial Public Offering
Sole Marketing Agent
$885.0 Million
PF
ProFrac Holding Corp.
Senior Secured Notes
Senior Secured Term Loan
Sole Placement Agent
$50.0 Million
OrthAlign
OrthAlign, Inc.
Senior Secured Term Loan
Sole Placement Agent
Integrity Implants Inc. (Accelus)
Senior Term Loan
Sole Placement Agent
$115.1 Million
Ocular
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$747.5 Million
Merit
Merit Medical Systems, Inc.
Convertible Offering
Active Bookrunner
$632.9 Million
Super
Super Micro Computer, Inc.
COnfidentially Marketed Follow-On Offering
Passive Bookrunner
AFIMAC
AFIMAC Global, Inc.
Senior Secured Debt
Sole Placement Agent
$175.3 Million
Skyward
Skyward Specialty Insurance
Follow-On Offering
Active Bookrunner
$20.0 Million
Arccos
Cobra
LionTree
PGA
Ping
Taylormade
Topgolf
Arccos Golf LLC
Arccos Golf LLC has received strategic investments from the PGA TOUR and golf’s top equipment manufacturers
Financial Advisor

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.